Estimation of regional lung function in interstitial pulmonary disease using 99mTc-technegas and 99mTc-macroaggregated albumin single-photon emission tomography. 1998

Y Sasaki, and T Imai, and T Shinkai, and H Ohishi, and H Otsuji, and H Uchida, and T Tokuyama, and K Hamada, and N Narita
Departments of Oncoradiology and Radiology, Nara Medical University, 840, Shijocho, Kashihara, Nara, Japan.

For quantitative evaluation of the regional lung function in patients with interstitial pulmonary disease (IP) in the sitting position, 99mTc-Technegas and 99mTc-macroaggregated albumin (MAA) single-photon emission tomography (SPET) studies were performed in 12 healthy controls (HC) and 42 IP patients. Four transverse images were prepared from the data obtained and designated as slices no. 1-4 from the top downward. Regions of interest (ROIs) were determined in the anterior and posterior parts of the lung in each slice, and the ratio of the count per voxel in the ROIs to the count in the entire lung was calculated as the regional Technegas index (T). The regional perfusion index (Q) was calculated by a similar procedure using the data of 99mTc-MAA SPET. The ratios between T and Q (T/Q) in the anterior and posterior regions of the lung, and the ratios of T and Q between the anterior and posterior regions of the lung (Tp/Ta and Qp/Qa) were examined. In the HC group, T/Q decreased but Tp/Ta and Qp/Qa increased from the upper to the lower lung fields. When IP patients were classified into (I) those in whom T/Q decreased from the upper to the lower lung fields, (II) those in whom it was similar in all slices, (III) those in whom it increased from slice 3 to slice 4, and (IV) those in whom it increased from slice 2 to slices 3 and 4, this classification was more closely correlated with %VC than with %DLCO or PaO2. When the patients were classified according to Tp/Ta and Qp/Qa into (A) those in whom the values were greater in the lower than the upper lung field, (B) those in whom the values were similar in all slices, and (C) those in whom the values were smaller in lower than in upper lung fields, categories B and C were observed frequently even in patients whose %VC was in the normal range. This method is considered to be an effective means to evaluate the progression and pathology of IP and to detect early impairment of lung function.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006108 Graphite An allotropic form of carbon that is used in pencils, as a lubricant, and in matches and explosives. It is obtained by mining and its dust can cause lung irritation. Graphene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D013668 Technetium Tc 99m Aggregated Albumin A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in cardiovascular and cerebral circulation. Tc 99m-Albumin,Tc 99m-Albumin Colloid,99m-Tc-HSA,99mTc-Albures,99mTc-HSA,99mTc-Human Serum Albumin,Tc-99m-HAM,Tc-99m-MAA,Tc-99m-Microalbumin,Tc-HAMM,Tc99m-Albumin,Technetium-99m Albumin Colloid,99mTc Albures,99mTc Human Serum Albumin,99mTcAlbures,Albumin Colloid, Technetium-99m,Albumin, 99mTc-Human Serum,Colloid, Tc 99m-Albumin,Colloid, Technetium-99m Albumin,Serum Albumin, 99mTc-Human,Tc 99m Albumin,Tc 99m Albumin Colloid,Tc 99m HAM,Tc 99m MAA,Tc 99m Microalbumin,Tc HAMM,Tc99m Albumin,Technetium 99m Albumin Colloid

Related Publications

Y Sasaki, and T Imai, and T Shinkai, and H Ohishi, and H Otsuji, and H Uchida, and T Tokuyama, and K Hamada, and N Narita
February 2021, Nuclear medicine communications,
Y Sasaki, and T Imai, and T Shinkai, and H Ohishi, and H Otsuji, and H Uchida, and T Tokuyama, and K Hamada, and N Narita
January 2016, Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India,
Y Sasaki, and T Imai, and T Shinkai, and H Ohishi, and H Otsuji, and H Uchida, and T Tokuyama, and K Hamada, and N Narita
March 1986, Radioisotopes,
Y Sasaki, and T Imai, and T Shinkai, and H Ohishi, and H Otsuji, and H Uchida, and T Tokuyama, and K Hamada, and N Narita
January 2019, World journal of nuclear medicine,
Y Sasaki, and T Imai, and T Shinkai, and H Ohishi, and H Otsuji, and H Uchida, and T Tokuyama, and K Hamada, and N Narita
October 2020, Medical mycology,
Y Sasaki, and T Imai, and T Shinkai, and H Ohishi, and H Otsuji, and H Uchida, and T Tokuyama, and K Hamada, and N Narita
January 2020, Fujita medical journal,
Y Sasaki, and T Imai, and T Shinkai, and H Ohishi, and H Otsuji, and H Uchida, and T Tokuyama, and K Hamada, and N Narita
January 1994, Scandinavian journal of gastroenterology. Supplement,
Y Sasaki, and T Imai, and T Shinkai, and H Ohishi, and H Otsuji, and H Uchida, and T Tokuyama, and K Hamada, and N Narita
September 1987, Journal of neurology, neurosurgery, and psychiatry,
Y Sasaki, and T Imai, and T Shinkai, and H Ohishi, and H Otsuji, and H Uchida, and T Tokuyama, and K Hamada, and N Narita
February 1991, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
Y Sasaki, and T Imai, and T Shinkai, and H Ohishi, and H Otsuji, and H Uchida, and T Tokuyama, and K Hamada, and N Narita
October 1997, European journal of nuclear medicine,
Copied contents to your clipboard!